International Journal of Peptide Research and Therapeutics
Scope & Guideline
Fostering Global Collaboration in Peptide Innovation.
Introduction
Aims and Scopes
- Therapeutic Applications of Peptides:
The journal investigates the use of peptides in various therapeutic contexts, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory applications. This includes the study of naturally occurring peptides, synthetic analogs, and engineered peptide constructs. - Peptide Design and Engineering:
Research published in this journal often focuses on the design, synthesis, and characterization of novel peptides. This includes the use of computational approaches, molecular docking, and structure-activity relationship studies to optimize peptide efficacy and specificity. - Mechanisms of Action:
The journal emphasizes understanding the biochemical and molecular mechanisms through which peptides exert their effects, including studies on signal transduction pathways, receptor interactions, and cellular responses. - Bioinformatics and Computational Modeling:
A significant portion of the research involves computational methods for predicting peptide interactions, designing peptide-based vaccines, and simulating the behavior of peptides in biological systems. - Natural Product Research:
The journal highlights the exploration of peptides derived from natural sources, including plants, animals, and microorganisms, and their potential therapeutic benefits. - Multidisciplinary Approaches to Peptide Research:
Research often integrates various scientific disciplines such as biochemistry, molecular biology, pharmacology, and materials science to advance the field of peptide therapeutics.
Trending and Emerging
- Antimicrobial Peptides (AMPs):
There is a growing body of research focused on the discovery, characterization, and application of antimicrobial peptides as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant pathogens. - Peptide Vaccines:
The development of peptide-based vaccines, particularly in response to emerging infectious diseases such as COVID-19, has gained significant attention, with many studies exploring immunogenicity and efficacy. - Peptides in Cancer Therapy:
Research on peptides that target cancer cells, including their mechanisms of action and potential as therapeutic agents, is rapidly expanding, with a focus on novel delivery systems and combination therapies. - AI and Machine Learning in Peptide Design:
The integration of artificial intelligence and machine learning techniques in peptide design and optimization is emerging as a powerful tool, enhancing the ability to predict peptide interactions and therapeutic potential. - Natural and Synthetic Hybrid Peptides:
There is an increasing interest in hybrid peptides that combine properties of natural and synthetic peptides, aiming to enhance stability and efficacy for therapeutic applications. - Peptides for Neurological Disorders:
Research on the role of peptides in the treatment of neurological conditions, including neurodegenerative diseases and neuroinflammation, is on the rise, highlighting their therapeutic potential in the central nervous system.
Declining or Waning
- Traditional Antibiotics:
There appears to be a waning interest in the development of traditional peptide antibiotics as researchers increasingly focus on innovative approaches, such as multifunctional peptides or peptide-drug conjugates, to combat antibiotic resistance. - Peptides for General Health Supplements:
Research focused on the use of peptides exclusively for general health benefits or as dietary supplements is becoming less prominent, indicating a shift toward more targeted therapeutic applications. - Peptide-Based Diagnostics:
The exploration of peptides specifically for diagnostic applications has decreased, possibly as the field shifts towards integrated approaches that combine diagnostics with therapeutic interventions. - Basic Research in Peptide Chemistry:
While fundamental studies are essential, there is a noticeable decline in publications that focus solely on the basic chemistry of peptides without direct therapeutic implications, reflecting a trend toward more applied research.
Similar Journals
ACS Bio & Med Chem Au
Connecting research and clinical applications for a healthier tomorrow.ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.
European Journal of Medicinal Chemistry Reports
Fostering collaboration for groundbreaking medicinal advancements.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
BIOCHEMICAL PHARMACOLOGY
Uniting science and medicine for impactful pharmaceutical advancements.BIOCHEMICAL PHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, stands as a leading international journal devoted to the advancing field of biochemical pharmacology. Since its inception in 1958, the journal has continuously offered a platform for innovative research, delivering critical insights into the interaction between biochemical processes and pharmaceutical applications, and now converges towards its 2024 edition. With an impressive Q1 ranking in both Biochemistry and Pharmacology categories, it ranks 32nd out of 313 in Pharmacology and Toxicology, and 58th out of 438 in Biochemistry according to Scopus, showcasing its significant impact within the scientific community. Researchers and professionals rely on this journal to keep abreast of essential developments, given its robust peer-review process and a comprehensive selection of articles that span experimental studies, clinical trials, and theoretical analyses. Although not an Open Access journal, it remains pivotal for those seeking to advance their knowledge in the dynamic fields of biochemistry and pharmacology. With its high impact factor and emphasis on quality research, BIOCHEMICAL PHARMACOLOGY continues to be an invaluable resource for students, researchers, and industry professionals striving to make breakthroughs in drug development and therapeutic strategies.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Unveiling the complexities of molecular life.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Elevating Scientific Dialogue in Health ResearchCLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.
Tissue Engineering and Regenerative Medicine
Pioneering Solutions in Tissue Restoration and RepairTissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.
PROTEIN AND PEPTIDE LETTERS
Illuminating the dynamic landscape of protein and peptide studies.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
LETTERS IN ORGANIC CHEMISTRY
Pioneering Discoveries in Organic ChemistryLETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.
JOURNAL OF PEPTIDE SCIENCE
Pioneering insights into peptide chemistry and drug discovery.JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.
International Journal of Pharmaceutics
Exploring the forefront of pharmacology and toxicology.The International Journal of Pharmaceutics, a prestigious publication from ELSEVIER, stands at the forefront of the pharmaceutical science field, exemplified by its impressive ranking of #15 out of 183 in Pharmacology, Toxicology, and Pharmaceutics, placing it in the 92nd percentile. Established in 1978, this journal has continuously provided a platform for researchers, professionals, and students to share groundbreaking discoveries and innovations in drug formulation, delivery systems, and pharmacokinetics. With a Q1 ranking in the 2023 category of Pharmaceutical Science, it underscores its significance in disseminating high-quality research that shapes clinical practices and enhances therapeutic outcomes. While the journal does not currently offer open access options, it remains accessible to subscribers through its publication based in Amsterdam, Netherlands, ensuring a broad reach within the scientific community. As it converges towards a vibrant future, the International Journal of Pharmaceutics continues to be an essential resource for anyone dedicated to advancing the field of pharmacy and drug development.